[Warfarin-bosentan interaction. Risk of big INR changes].
Holm
Lennart
L
Karolinska Universitetssjukhuset, Stockholm. lennart.holm@karolinska.se
Jansson
Asa
A
Noher
Hans
H
D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000009:adverse effects*; D000959:Antihypertensive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D000077300:Bosentan; D004305:Dose-Response Relationship, Drug; D004347:Drug Interactions; D006801:Humans; D019934:International Normalized Ratio; D008297:Male; D013449:Sulfonamides / Q000008:administration & dosage / Q000009:adverse effects*; D014859:Warfarin / Q000008:administration & dosage / Q000009:adverse effects*